Macrophages as tools and targets in cancer therapy

A Mantovani, P Allavena, F Marchesi… - Nature Reviews Drug …, 2022 - nature.com
Tumour-associated macrophages are an essential component of the tumour
microenvironment and have a role in the orchestration of angiogenesis, extracellular matrix …

[HTML][HTML] Macrophages at the interface of the co-evolving cancer ecosystem

DJ Kloosterman, L Akkari - Cell, 2023 - cell.com
Macrophages are versatile and heterogeneous innate immune cells undertaking central
functions in balancing immune responses and tissue repair to maintain homeostasis. This …

[HTML][HTML] Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer

RN Ramos, Y Missolo-Koussou, Y Gerber-Ferder… - Cell, 2022 - cell.com
Macrophage infiltration is a hallmark of solid cancers, and overall macrophage infiltration
correlates with lower patient survival and resistance to therapy. Tumor-associated …

Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations

LH Butterfield, YG Najjar - Nature Reviews Immunology, 2024 - nature.com
The approval of the first immune checkpoint inhibitors provided a paradigm shift for the
treatment of malignancies across a broad range of indications. Whereas initially, single …

Targeting macrophages in hematological malignancies: recent advances and future directions

W Li, F Wang, R Guo, Z Bian, Y Song - Journal of hematology & oncology, 2022 - Springer
Emerging evidence indicates that the detection and clearance of cancer cells via
phagocytosis induced by innate immune checkpoints play significant roles in tumor …

Control of tumor-associated macrophage responses by nutrient acquisition and metabolism

X Zhang, L Ji, MO Li - Immunity, 2023 - cell.com
Metazoan tissue specification is associated with integration of macrophage lineage cells in
sub-tissular niches to promote tissue development and homeostasis. Oncogenic …

The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer

A Chow, FZ Uddin, M Liu, A Dobrin, BY Nabet… - Immunity, 2023 - cell.com
Improved identification of anti-tumor T cells is needed to advance cancer immunotherapies.
CD39 expression is a promising surrogate of tumor-reactive CD8+ T cells. Here, we …

Extracellular‐vesicle‐based drug delivery systems for enhanced antitumor therapies through modulating the cancer‐immunity cycle

T Yong, Z Wei, L Gan, X Yang - Advanced Materials, 2022 - Wiley Online Library
Although immunotherapy harnessing activity of the immune system against tumors has
made great progress, the treatment efficacy remains limited in most cancers. Current …

Extracellular vesicles remodel tumor environment for cancer immunotherapy

M Yue, S Hu, H Sun, B Tuo, B Jia, C Chen, W Wang… - Molecular Cancer, 2023 - Springer
Tumor immunotherapy has transformed neoplastic disease management, yet low response
rates and immune complications persist as major challenges. Extracellular vesicles …

[HTML][HTML] Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

G Fucà, R Cohen, S Lonardi, K Shitara… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Despite unprecedented benefit from immune checkpoint inhibitors (ICIs) in
patients with mismatch repair deficient (dMMR)/microsatellite instability high (MSI-H) …